Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-May-24 4:06 PM View:  | Aastrom Biosciences, Inc. (VCEL) | 01-May-24 | Option Exercise | 3,200 | -- | -- | 12% 26.8K to 30.0K | |
| 15-Dec-23 4:07 PM View: | Aastrom Biosciences, Inc. (VCEL) | 14-Dec-23 | Market Sale | 5,000 | $37.31 | $186,550.00 | (16%) 31.8K to 26.8K | (4%) |
| 28-Apr-23 4:04 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-23 | Option Exercise | 2,600 | -- | -- | 9% 29.2K to 31.8K | |
| 29-Apr-22 4:14 PM View: | Aastrom Biosciences, Inc. (VCEL) | 27-Apr-22 | Option Exercise | 2,600 | -- | -- | 10% 26.6K to 29.2K | |
| 17-May-21 4:39 PM View: | Aastrom Biosciences, Inc. (VCEL) | 14-May-21 | Market Sale | 5,000 | $50.52 | $252,611.00 | (16%) 31.6K to 26.6K | (< 1%) |
| 13-May-21 4:50 PM View: | Aastrom Biosciences, Inc. (VCEL) | 12-May-21 | Market Option Sale | 2,200 | $48.88 | $107,534.00 | (7%) 33.8K to 31.6K | |
| 13-May-21 4:50 PM View: | Aastrom Biosciences, Inc. (VCEL) | 11-May-21 | Option Exercise | 43,750 | $14.57 | $637,612.00 | 1250% 3.5K to 47.25K | |
| 13-May-21 4:50 PM View: | Aastrom Biosciences, Inc. (VCEL) | 11-May-21 | Market Option Sale | 13,448 | $50.11 | $673,922.00 | (28%) 47.25K to 33.8K | |
| 30-Apr-21 4:03 PM View: | Aastrom Biosciences, Inc. (VCEL) | 28-Apr-21 | Option Exercise | 1,750 | -- | -- | 100% 1.75K to 3.5K | |
| 01-May-20 4:12 PM View: | Aastrom Biosciences, Inc. (VCEL) | 29-Apr-20 | Option Exercise | 1,750 | -- | -- | 100% 0 to 1.75K | |
| 04-Jan-19 4:13 PM View: | Aastrom Biosciences, Inc. (VCEL) | 02-Jan-19 | Option Exercise | 22,500 | $2.66 | $59,825.00 | 100% 0 to 22.5K | |
| 04-Jan-19 4:13 PM View: | Aastrom Biosciences, Inc. (VCEL) | 02-Jan-19 | Market Option Sale | 22,500 | $16.83 | $378,693.00 | (100%) 22.5K to 0 | |
| 20-Jun-18 2:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 18-Jun-18 | Option Exercise | 30,000 | $3.41 | $102,400.00 | 100% 0 to 30.0K | |
| 20-Jun-18 2:05 PM View: | Aastrom Biosciences, Inc. (VCEL) | 18-Jun-18 | Market Option Sale | 30,000 | $12.06 | $361,800.00 | (100%) 30.0K to 0 | |
| 11-Feb-16 4:26 PM View: | Advanced Cell Technology Inc. (ACTC) | 10-Feb-16 | Disposition (change in control) | 277,500 | $8.50 | $2,358,750.00 | (100%) 277.5K to 0 | |
| 31-Jul-15 4:14 PM View: | Advanced Cell Technology Inc. (ACTC) | 30-Jul-15 | Payment of Exercise | 32,500 | $4.23 | $137,475.00 | (11%) 300.0K to 267.5K | |
| 09-Mar-15 4:18 PM View: | Advanced Cell Technology Inc. (ACTC) | 05-Mar-15 | Grant | 10,000 | -- | -- | 3% 300.0K to 310.0K | |
| 31-Jul-14 4:40 PM View: | Advanced Cell Technology Inc. (ACTC) | 30-Jul-14 | Grant | 30,000,000 | -- | -- | 100% 0 to 30.0M | |
| 02-Jun-14 4:57 PM View: | Antares Pharma Inc. (ATRS) | 29-May-14 | Grant | 266,991 | -- | -- | 40% 670.73K to 937.73K | |
| 24-Feb-14 5:51 PM View: | Antares Pharma Inc. (ATRS) | 20-Feb-14 | Grant | 10,309 | -- | -- | 2% 663.73K to 674.04K | |
| 24-Feb-14 5:51 PM View: | Antares Pharma Inc. (ATRS) | 20-Feb-14 | Payment of Exercise | 3,309 | $4.85 | $16,048.60 | (< 1%) 674.04K to 670.73K | 18% |
| 13-Feb-14 8:40 PM View: | Antares Pharma Inc. (ATRS) | 11-Feb-14 | Disposition | 34,000 | -- | -- | (5%) 708.73K to 674.73K | |
| 13-Feb-14 8:40 PM View: | Antares Pharma Inc. (ATRS) | 11-Feb-14 | Payment of Exercise | 11,000 | $4.45 | $48,950.00 | (2%) 674.73K to 663.73K | 10% |
| 17-Jan-14 4:22 PM View: | Antares Pharma Inc. (ATRS) | 15-Jan-14 | Option Exercise | 22,900 | $0.50 | $11,450.00 | 3% 708.73K to 731.63K | |
| 17-Jan-14 4:22 PM View: | Antares Pharma Inc. (ATRS) | 15-Jan-14 | Market Option Sale (Planned) | 22,900 | $5.10 | $116,758.00 | (3%) 731.63K to 708.73K | 22% |
| 10-Dec-13 5:06 PM View: | Antares Pharma Inc. (ATRS) | 09-Dec-13 | Option Exercise | 18,100 | $0.50 | $9,050.00 | 3% 708.73K to 726.83K | |
| 10-Dec-13 5:06 PM View: | Antares Pharma Inc. (ATRS) | 09-Dec-13 | Market Option Sale (Planned) | 18,100 | $4.00 | $72,447.10 | (2%) 726.83K to 708.73K | < 1% |
| 10-Dec-13 5:06 PM View: | Antares Pharma Inc. (ATRS) | 06-Dec-13 | Option Exercise | 46,000 | $0.50 | $23,000.00 | 6% 708.73K to 754.73K | |
| 10-Dec-13 5:06 PM View: | Antares Pharma Inc. (ATRS) | 06-Dec-13 | Market Option Sale (Planned) | 46,000 | $4.00 | $184,198.00 | (6%) 754.73K to 708.73K | < 1% |
| 03-Oct-13 4:27 PM View: | Antares Pharma Inc. (ATRS) | 01-Oct-13 | Option Exercise | 35,000 | $0.50 | $17,500.00 | 5% 708.73K to 743.73K | |
| 03-Oct-13 4:27 PM View: | Antares Pharma Inc. (ATRS) | 01-Oct-13 | Market Option Sale (Planned) | 35,000 | $4.19 | $146,510.00 | (5%) 743.73K to 708.73K | 5% |
| 05-Sep-13 4:42 PM View: | Antares Pharma Inc. (ATRS) | 03-Sep-13 | Option Exercise | 35,000 | $0.50 | $17,500.00 | 5% 708.73K to 743.73K | |
| 05-Sep-13 4:42 PM View: | Antares Pharma Inc. (ATRS) | 03-Sep-13 | Market Option Sale (Planned) | 35,000 | $4.41 | $154,378.00 | (5%) 743.73K to 708.73K | 10% |
| 05-Aug-13 4:35 PM View: | Antares Pharma Inc. (ATRS) | 01-Aug-13 | Option Exercise | 35,000 | $0.50 | $17,500.00 | 5% 708.73K to 743.73K | |
| 05-Aug-13 4:35 PM View: | Antares Pharma Inc. (ATRS) | 01-Aug-13 | Market Option Sale (Planned) | 35,000 | $4.42 | $154,592.00 | (5%) 743.73K to 708.73K | 10% |
| 03-Jul-13 4:44 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Option Exercise | 35,000 | $0.50 | $17,500.00 | 5% 708.73K to 743.73K | |
| 03-Jul-13 4:43 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Option Exercise Duplicate | 35,000 | $0.50 | $17,500.00 | 5% 708.73K to 743.73K | |
| 03-Jul-13 4:44 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Market Option Sale (Planned) | 35,000 | $4.14 | $144,974.00 | (5%) 743.73K to 708.73K | 4% |
| 03-Jul-13 4:43 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Market Option Sale (Planned) Duplicate | 35,000 | $4.14 | $144,974.00 | (5%) 743.73K to 708.73K | 4% |
| 05-Jun-13 4:39 PM View: | Antares Pharma Inc. (ATRS) | 03-Jun-13 | Option Exercise | 125,000 | $0.50 | $62,500.00 | 18% 708.73K to 833.73K | |
| 05-Jun-13 4:39 PM View: | Antares Pharma Inc. (ATRS) | 03-Jun-13 | Market Option Sale (Planned) | 125,000 | $4.01 | $501,138.00 | (15%) 833.73K to 708.73K | < 1% |
| 24-May-13 4:45 PM View: | Antares Pharma Inc. (ATRS) | 22-May-13 | Grant | 185,186 | -- | -- | 35% 523.55K to 708.73K | |
| 08-May-13 5:53 PM View: | Antares Pharma Inc. (ATRS) | 06-May-13 | Option Exercise | 10,000 | $0.50 | $5,000.00 | 2% 523.55K to 533.55K | |
| 08-May-13 5:53 PM View: | Antares Pharma Inc. (ATRS) | 06-May-13 | Market Option Sale (Planned) | 10,000 | $4.03 | $40,350.00 | (2%) 533.55K to 523.55K | 1% |
| 10-Jan-13 4:35 PM View: | Antares Pharma Inc. (ATRS) | 08-Jan-13 | Option Exercise | 25,000 | $0.50 | $12,500.00 | 5% 537.39K to 562.39K | |
| 10-Jan-13 4:35 PM View: | Antares Pharma Inc. (ATRS) | 08-Jan-13 | Market Option Sale (Planned) | 25,000 | $4.01 | $100,300.00 | (4%) 562.39K to 537.39K | < 1% |
| 06-Dec-12 4:41 PM View: | Antares Pharma Inc. (ATRS) | 04-Dec-12 | Option Exercise | 25,000 | $0.50 | $12,500.00 | 5% 537.39K to 562.39K | |
| 06-Dec-12 4:41 PM View: | Antares Pharma Inc. (ATRS) | 04-Dec-12 | Market Option Sale (Planned) | 25,000 | $4.00 | $100,008.00 | (4%) 562.39K to 537.39K | < 1% |
| 10-Jul-12 6:09 PM View: | Antares Pharma Inc. (ATRS) | 06-Jul-12 | Grant | 54,773 | -- | -- | 11% 482.62K to 537.39K | |
| 13-Feb-12 5:28 PM View: | Antares Pharma Inc. (ATRS) | 10-Feb-12 | Grant | 6,948 | -- | -- | 1% 475.67K to 482.62K |